Sinclair Pharma Plc

United Kingdom Country flag United Kingdom
Sector: Pharmaceuticals
Ticker: SPH
ISIN: GB0033856740
Factsheet Factsheet
INACTIVE

Profitability Analysis of Sinclair Pharma Plc ( SPH | GBR)

The Profitability Score is a relevant measure for the assessment of a stock attractiveness. Sinclair Pharma Plc shows a Profitability Score of N/A.
The Profitability Score for Sinclair Pharma Plc is lower than its peer group's. This means that Sinclair Pharma Plc has a lower profitability than its peer group.

Valuation
EV/EBITDA LastEV/EBITDA(e) 2024EV/EBITDA NTM
International PeersFree trialFree trialFree trial
PharmaceuticalsN/A6.636.86
N/AN/AN/AN/A
United KingdomN/A7.166.33
More...
Betanull
Levered betaUnlevered beta
1-YearN/AN/A
2-YearN/AN/A
3-YearN/AN/A
More...
Stock Perf excl. Dividends (in N/A)
SPHN/ARel. Perf.
Year-to-DateN/AN/AN/A
1-WeekN/AN/AN/A
1-MonthN/AN/AN/A
1-YearN/AN/AN/A
3-YearN/AN/AN/A
5-YearN/AN/AN/A
More...
GPRV Analysis
GPRV® analysis is not available due to one of the
following reasons:
  • - Company is not covered by analysts (no estimates)
  • - Company is an insurance company
More...
International Peers - Sinclair Pharma Plc
Company NameCtryMarket
Cap.
last (mUSD)
Sinclair Pharma PlcGBRN/A
International Peers Median
IPCA Laboratories Limit...INDN/A
Glenmark Pharmaceutical...IND5 067
GT biopharma Inc.USAN/A
Divi's Laboratories Lim...IND20 780
Piramal Enterprises Ltd...IND3 012
Net Sales
No data available for this instrument.
Quotes Chart

1-Year Rebased Stock Chart

  • Sinclair Pharma Plc
Created with Highcharts 4.1.7
No data to display
More...

About Stock Profitability Analysis

Aggregated Profitability Score
In GPRV, the Aggregated Profitability Score is the average of the profitability indicators' scores.

EBIT Margin Historical
This is a weighted average of the Historical EBIT Margins.
Calculation: (using up to 5 years of historical data when available)
[EBIT Margin year N*5 + EBIT Margin year (N-1)*4 + EBIT Margin year (N-2)*3 + EBIT Margin year (N-3)*2 + EBIT Margin (N-4)] / 15

EBIT Margin NTM
This is an estimate for EBIT Margin over the Next Twelve Months.
Calculation:
EBIT NTM / Net Sales NTM using estimates consensus for EBIT and Net Sales

ROCE Historical
This is a weighted average of the Historical Returns On Capital Employed.
Calculation: (using up to 5 years of historical data when available)
[ROCE year N*5 + ROCE year (N-1)*4 + ROCE year (N-2)*3 + ROCE year (N-3)*2 + ROCE year (N-4)] / 15

ROE Last
ROE (Return on Equity) is one of the most widely used measures of how well a company is performing for its shareholders, as it indicates how much was earned for each unit invested by the owners. It is a relatively straightforward benchmark for investors to compare the company's use of its equity against other investments.
Calculation:
ROE=Net profit after preferred dividends (Last) / Average total equity for the last 2 years (in %)

Dividend Yield NTM
This is an estimate for Dividend Yield over the Next Twelve Months.
Calculation:
The median of dividend per share estimates divided by the last share price.